Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-23-026178

Options or other derivatives

  • Director acquired 18,475 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Svoronos Dawn Director 2023-06-02 Grant or award · Stock Option (Right to Buy) +18,475 18,475 D
Loading xslF345X04/ownership.xml…